Chargement en cours...
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
BACKGROUND: The article aims to compare the efficiency of minimax, optimal and admissible criteria in Simon’s and Fleming’s two-stage design. METHODS: Three parameter settings (p(1)-p(0) = 0.25–0.05, 0.30–0.10, 0.50–0.30) are designed to compare the maximum sample size, the critical values and the e...
Enregistré dans:
| Publié dans: | BMC Med Res Methodol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7240995/ https://ncbi.nlm.nih.gov/pubmed/32434577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-020-01017-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|